Source comparison
BPC-157 Nerve Repair Results Timeline: Comparison Across Injury Types
Sciatic nerve crush (rat) 30–50mm 14–21 days (partial toe spread, CMAP 40–50% baseline) 8–12 weeks (≥90% CMAP, normal gait) 3–6 months for comparable peripheral nerve crush in humans BPC-157 accelerates remyelination and reduces aberrant sprouting—effect size
This comparison does not assign a generated winner or score.
- Sciatic nerve crush (rat)
- 30–50mm
- 14–21 days (partial toe spread, CMAP 40–50% baseline)
- 8–12 weeks (≥90% CMAP, normal gait)
- 3–6 months for comparable peripheral nerve crush in humans
- BPC-157 accelerates remyelination and reduces aberrant sprouting—effect size strongest in crush injuries where endoneurial tube remains intact
- Sciatic nerve transection + repair (rat)
- 21–28 days (minimal voluntary contraction)
- 12–16 weeks (60–70% functional recovery)
- 6–12 months for surgical nerve repair in humans
- Transection outcomes depend on surgical coaptation quality—BPC-157 enhances axonal pathfinding but cannot compensate for misalignment
- Median nerve compression (human wrist)
- 50–80mm
- 4–6 weeks (reduced paresthesia, improved two-point discrimination)
- 12–16 weeks (nerve conduction velocity 80–90% contralateral side)
- 3–4 months for mild-to-moderate carpal tunnel cases
- Compression neuropathy responds faster than traumatic injury because baseline Schwann cell architecture is preserved
- Brachial plexus avulsion (C5-C6 roots)
- 200–400mm
- 8–12 weeks (minimal proximal muscle activation)
- 12–24 months (variable—often incomplete)
- 12–24+ months with nerve grafting + adjunctive therapy
- BPC-157 may reduce secondary muscle atrophy during reinnervation lag, but outcome ceiling is determined by injury severity and surgical intervention